Fairvalue-Calculator Fairvalue-Calculator
EN DE

Apex Biotechnology Corp (1733) Fair Value & Analysis

Healthcare · TW · Market cap 2.9B TWD

Price29.45 TWD
Fair Value31.46 TWD
Upside+6.8%
Quality95/100
Evidence: High Range 23.15 TWD – 39.49 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Apex Biotechnology Corp (1733) currently trades at 29.45 TWD, while our model-based Fair Value estimate is 31.46 TWD — implying the stock looks roughly 6.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Apex Biotechnology Corp (1733) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 31.46 TWD versus a price of 29.45 TWD — about +7% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 1733?
Our 21-model fair value for Apex Biotechnology Corp is 31.46 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 29.45 TWD.
What is the quality score of 1733?
Apex Biotechnology Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.